14.53
Schlusskurs vom Vortag:
$14.22
Offen:
$14.21
24-Stunden-Volumen:
277.57K
Relative Volume:
0.64
Marktkapitalisierung:
$670.25M
Einnahmen:
$524.73M
Nettoeinkommen (Verlust:
$31.70M
KGV:
21.96
EPS:
0.6617
Netto-Cashflow:
$22.47M
1W Leistung:
+5.87%
1M Leistung:
-16.76%
6M Leistung:
-2.84%
1J Leistung:
+33.87%
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Compare CLB vs SLB, BKR, HAL, TS, FTI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CLB
Core Laboratories Inc
|
14.54 | 655.49M | 524.73M | 31.70M | 22.47M | 0.6617 |
|
SLB
Slb Ltd
|
58.43 | 85.64B | 35.91B | 3.38B | 4.41B | 2.2806 |
|
BKR
Baker Hughes Company
|
67.09 | 65.54B | 27.89B | 3.15B | 2.29B | 3.1363 |
|
HAL
Halliburton Co
|
41.33 | 34.64B | 22.17B | 1.55B | 1.68B | 1.8227 |
|
TS
Tenaris Sa Adr
|
62.62 | 31.10B | 12.19B | 2.03B | 1.87B | 3.8072 |
|
FTI
Technipfmc Plc
|
71.04 | 28.30B | 10.17B | 1.08B | 1.34B | 2.6138 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
Implied volatility surging for Core Laboratories stock options - MSN
How Core Laboratories Inc. (CLB) Affects Rotational Strategy Timing - Stock Traders Daily
CLB News | CORE LABORATORIES INC (NYSE:CLB) - ChartMill
Implied Volatility Surging for Core Laboratories Stock Options - Yahoo Finance
Borr Drilling and Core Laboratories Shares Are Soaring, What You Need To Know - TradingView
Core Laboratories Inc expected to post earnings of 12 cents a shareEarnings Preview - TradingView
Disciplined Growth Investors holds 4.94M CLB shares (NYSE: CLB) - Stock Titan
CLB Stock Price, Quote & Chart | CORE LABORATORIES INC (NYSE:CLB) - ChartMill
Core Laboratories Shareholders Back Directors, Auditor and Pay - The Globe and Mail
Core Laboratories Inc. Common Stock (NY: CLB - FinancialContent
Core Laboratories shareholders approve director elections and executive compensation - Investing.com UK
Core Laboratories shareholders approve director elections and executive compensation By Investing.com - Investing.com Nigeria
Core Laboratories (NYSE: CLB) investors back directors, auditor and pay - Stock Titan
Core Lab projects Q2 2026 revenue of $123M-$131M and EPS of $0.06-$0.12 amid Middle East disruptions - MSN
Core Laboratories Inc.: - marketscreener.com
Number of shareholders of Core Laboratories Inc. – BMV:CLB - TradingView
Core Laboratories (NYSE:CLB) Downgraded by Wall Street Zen to Sell - MarketBeat
Why Core Laboratories (CLB) shares are sliding today - MSN
How Core Labs (CLB) differentiates itself from competitors (Breakdown Watch) 2026-05-08Viral Trade Signals - Newser
MSN Money - MSN
Core Laboratories and Helmerich & Payne Shares Are Falling, What You Need To Know - TradingView
Core Laboratories (NYSE: CLB) SVP exercises restricted shares, covers taxes - Stock Titan
Core Laboratories Q1 Earnings Meet Estimates, Decline Y/Y - Yahoo Finance
Top 3 Energy Stocks That May Jump In Q2 - Benzinga
Core Laboratories Inc. Q1 2026 SEC 10-Q Report: Financial Statements, Risk Factors, and Management Analysis - Minichart
Core Laboratories Earnings Call: Tech Strengths Amid Turmoil - The Globe and Mail
Core Laboratories (NYSE:CLB) Shares Down 6.7%Time to Sell? - MarketBeat
Why Core Laboratories (CLB) Shares Are Sliding Today - TradingView
Core Laboratories Inc (CLB) Q1 2026 Earnings Call Highlights: Na - GuruFocus
Core Laboratories Q1 Earnings Call Highlights - MarketBeat
Core Laboratories (NYSE: CLB) Q1 2026 revenue slips and results swing to loss - Stock Titan
Core Laboratories : 2025 Core Laboratories Annual Report - marketscreener.com
Core Lab (CLB) Q1 2026 Earnings Transcript - The Globe and Mail
Core Laboratories (NYSE:CLB) Shares Gap DownWhat's Next? - MarketBeat
Earnings call transcript: Core Laboratories Q1 2026 results miss expectations By Investing.com - Investing.com Canada
Earnings call transcript: Core Laboratories Q1 2026 results miss expectations - Investing.com
Core Laboratories Inc. (NYSE:CLB) to Issue Quarterly Dividend of $0.01 - MarketBeat
Core Laboratories N.V. Q1 2026 Earnings Call Summary - Yahoo Finance
Middle East conflict weighs on Core Laboratories' Q1 outlook - MSN
Core Lab (CLB) Reports Q1 Revenue Amid Geopolitical Challenges - GuruFocus
Is Core Laboratories (CLB) 8.2% Undervalued After Q1 2026? Adj. - GuruFocus
Core Laboratories Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Core Laboratories (NYSE:CLB) Issues Q2 2026 Earnings Guidance - MarketBeat
Core Laboratories Posts Flat Q1 2026 Results Amid Disruptions - TipRanks
Core Laboratories (NYSE:CLB) Posts Earnings Results, Hits Estimates - MarketBeat
Earnings Flash (CLB) Core Laboratories Inc. Reports Q1 Revenue $121.8M, vs. FactSet Est of $123.0M - marketscreener.com
Earnings Flash (CLB) Core Laboratories Inc. Posts Q1 Adjusted EPS $0.06 per Share, vs. FactSet Est of $0.09 - marketscreener.com
Core Laboratories: Q1 Earnings Snapshot - Barchart.com
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):